We’ve just had the first known case of psilocybin being delivered to patients through Canada’s Special Access Program (first since the regulatory amendment on January 5th).
In January, we covered the news that Canada Amended Special Access to Psychedelics, a major change in the federal government’s restrictions to psychedelic compounds.
Share this post
